4.8 Article

Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques

Keith D. Kauffman et al.

Summary: Blocking PD-1 increases the number and functionality of Mtb-specific CD8 T cells in granulomas of rhesus macaques, but has a lesser impact on CD4 T cells with more of an inhibitory effect.

SCIENCE IMMUNOLOGY (2021)

Article Oncology

Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors

Giuseppe Curigliano et al.

Summary: The study aimed to evaluate the safety and efficacy of Sabatolimab and spartalizumab in patients with advanced solid tumors. The results showed that the combination of Sabatolimab plus spartalizumab was well tolerated and showed signs of antitumor activity, with the recommended dose for Sabatolimab being 800 mg Q4W, with or without 400 mg spartalizumab Q4W.

CLINICAL CANCER RESEARCH (2021)

Review Oncology

TIM-3 in Leukemia; Immune Response and Beyond

Mahnaz Rezaei et al.

Summary: TIM-3 expression in leukemia cells plays a role in immune escape. TIM-3 inhibitors show promising responses in MDS and AML treatment. Blocking TIM-3 may have dual effects by inhibiting leukemia cell proliferation and restoring T cell function, but its effects may differ in different types of leukemia, requiring further research.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

First-in-human phase I/Ib open-label dose-escalation study of GWN323 (anti-GITR) as a single agent and in combination with spartalizumab (anti-PD-1) in patients with advanced solid tumors and lymphomas

Sarina A. Piha-Paul et al.

Summary: The study investigated the safety and efficacy of the antibody GWN323 in solid tumor patients. Results showed good tolerability of GWN323 as a single agent and in combination, with recommended doses of 1500mg q3w and GWN323 750 mg+spartalizumab 300mg q3w, respectively. Some treatment responses were observed in the combination arm.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Review Oncology

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade

Tian Tian et al.

Summary: Blocking therapy targeting programmed death receptor 1 (PD-1) or programmed death ligand 1 (PD-L1) has revolutionized the treatment of malignant tumors, but patient response rates are low and drug resistance is a major concern. Combining this therapy with Tim-3 blockade may offer a promising approach to overcoming resistance in cancer immunotherapy.

FRONTIERS IN ONCOLOGY (2021)

Article Immunology

Mycobacterium abscessus Clearance by Neutrophils Is Independent of Autophagy

Kerstin Pohl et al.

INFECTION AND IMMUNITY (2020)

Review Immunology

The Rise of Non-Tuberculosis Mycobacterial Lung Disease

Champa N. Ratnatunga et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Virology

Immune Checkpoints in Viral Infections

Huiming Cai et al.

VIRUSES-BASEL (2020)

Review Immunology

TIM3 comes of age as an inhibitory receptor

Yochai Wolf et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

Exploring immunomodulation by endocrine changes in Lady Windermere syndrome

M. R. Holt et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)

Article Immunology

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

Laura M. McLane et al.

Annual Review of Immunology (2019)

Review Biochemistry & Molecular Biology

Checkpoint Inhibition and Infectious Diseases: A Good Thing?

Michael S. Abers et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Article Infectious Diseases

Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK

Eleanor L. Axson et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2019)

Article Biochemistry & Molecular Biology

Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection

Steven A. Cowman et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Review Infectious Diseases

High mortality in patients with Mycobacterium avium complex lung disease: a systematic review

Roland Diel et al.

BMC INFECTIOUS DISEASES (2018)

Article Multidisciplinary Sciences

Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms

Kenneth C. Malcolm et al.

PLOS ONE (2018)

Article Multidisciplinary Sciences

Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion

Lyndsay Avery et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Immunology

Immune checkpoint blockade in infectious diseases

Michelle N. Wykes et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Respiratory System

Burden of non-tuberculous mycobacterial pulmonary disease in Germany

Roland Diel et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Review Biochemistry & Molecular Biology

Markers of T Cell Senescence in Humans

Weili Xu et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Review Immunology

The end of gating? An introduction to automated analysis of high dimensional cytometry data

Florian Mair et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2016)

Review Infectious Diseases

Update on pulmonary disease due to non-tuberculous mycobacteria

Jason E. Stout et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)

Article Multidisciplinary Sciences

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium

Josephine M. Bryant et al.

SCIENCE (2016)

Review Respiratory System

Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives

Yon Ju Ryu et al.

TUBERCULOSIS AND RESPIRATORY DISEASES (2016)

Article Respiratory System

The Treatment of Rapidly Growing Mycobacterial Infections

Shannon H. Kasperbauer et al.

CLINICS IN CHEST MEDICINE (2015)

Review Respiratory System

Epidemiology of Human Pulmonary Infection with Nontuberculous Mycobacteria A Review

D. Rebecca Prevots et al.

CLINICS IN CHEST MEDICINE (2015)

Article Cell Biology

Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response

Agnieszka Krupa et al.

MEDIATORS OF INFLAMMATION (2015)

Review Medicine, General & Internal

Management of nontuberculous mycobacterial infection in the elderly

Mehdi Mirsaeidi et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2014)

Article Infectious Diseases

Nontuberculous mycobacterial infections in children with inborn errors of the immune system

Margje H. Haverkamp et al.

JOURNAL OF INFECTION (2014)

Article Infectious Diseases

Occurrence of Nontuberculous Mycobacterial Pulmonary Infection in an Endemic Area of Tuberculosis

Ana Roberta Fusco da Costa et al.

PLOS NEGLECTED TROPICAL DISEASES (2013)

Article Biochemical Research Methods

SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets

Mario Roederer et al.

CYTOMETRY PART A (2011)

Article Critical Care Medicine

Nontuberculous Pulmonary Mycobacteriosis in Denmark Incidence and Prognostic Factors

Claire Andrejak et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Public, Environmental & Occupational Health

Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006

Jonathan E. Moore et al.

BMC PUBLIC HEALTH (2010)

Article Immunology

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Multidisciplinary Sciences

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection

Hyun-Tak Jin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis

Eszter Lazar-Molnar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Review Critical Care Medicine

An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

David E. Griffith et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Biochemistry & Molecular Biology

A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles

PK Chattopadhyay et al.

NATURE MEDICINE (2005)